Kim R. Tsuchimoto - 30 Jun 2022 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Signature
/s/ Kim R. Tsuchimoto
Issuer symbol
MNPR
Transactions as of
30 Jun 2022
Net transactions value
-$7,088
Form type
4
Filing time
01 Jul 2022, 16:05:34 UTC
Previous filing
01 Apr 2022
Next filing
03 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNPR Common Stock Options Exercise +8,913 +158% 14,549 30 Jun 2022 Direct F1
transaction MNPR Common Stock Tax liability $7,088 -3,083 -21% $2.30 11,466 30 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Restricted Stock Units Options Exercise $0 -8,913 -12% $0.000000 68,511 30 Jun 2022 Common Stock 8,913 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired on vesting and settlement of restricted stock units.
F2 On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
F3 On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.